Ohm , I have a question to you , so you thinking ,
Post# of 145265
![](/assets/46931549/no_avatar_available_thumb.jpg)
with close to 190K ...RS- HIV strain... available patients only in USA , our pps should be about 1.50..?
I am not sure if you remember , when Ibalizumab was approved for MDR3 , with about 25,000 available patients in USA ,
I believe March of 2018 , THERF went as high as about or above 11.00 doll. .
One year before I think they were about 1-1.50.
Just curious ..
Thank you ..
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)